Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:

Recent Articles in Trials & Approvals

RedCloud Doses NSCLC Patient in China Trial of Next-Gen EGFR TK
AlphaBio Completes Trials of Therapy for NSCLC with CNS Metastases
Clover Plans to Add Adolescents to List of Groups Approved for COVID-19 Vaccine
Ranok Starts Trials of BRD4 Protein Degradation Therapy for Solid Tumors
Sirnaomics Starts US Trial of siRNA Therapy for Squamous Cell Skin Cancer
ChinaBio Event
Beijing and Digital
November 8-11, 2022
ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes

Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
July 27-31, 2022